Thomas P. Burris

Overview

Best Publications

• Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA.

  Vikas Chandra;Pengxiang Huang;Yoshitomo Hamuro;Srilatha Raghuram

  912
  Citations

• Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

  Laura A. Solt;Yongjun Wang;Subhashis Banerjee;Travis G Hughes

  790
  Citations

• Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ

  Srilatha Raghuram;Keith R Stayrook;Pengxiang Huang;Pamela M Rogers

  646
  Citations

• Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.

  K. Ganesh Kumar;James L. Trevaskis;Daniel D. Lam;Gregory M. Sutton

  586
  Citations

• Suppression of TH17 Differentiation and Autoimmunity by a Synthetic ROR Ligand

  Laura A. Solt;P. Naresh Kumar;Philippe Nuhant;Yongjun Wang

  577
  Citations

• REV-ERB and ROR nuclear receptors as drug targets

  Douglas J. Kojetin;Thomas P. Burris

  529
  Citations

• Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy.

  Estelle Woldt;Yasmine Sebti;Laura A Solt;Christian Duhem

  434
  Citations

• Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis

  Guoqing Cao;Yu Liang;Carol L. Broderick;Brian A. Oldham

  405
  Citations

• The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor-α/γ Inverse Agonist

  Naresh Kumar;Laura A. Solt;Juliana J. Conkright;Yongjun Wang

  358
  Citations

• A Dominant-negative Peroxisome Proliferator-activated Receptor γ (PPARγ) Mutant Is a Constitutive Repressor and Inhibits PPARγ-mediated Adipogenesis

  M Gurnell;J M Wentworth;M Agostini;M Adams

  354
  Citations

• The coactivator LXXLL nuclear receptor recognition motif

  R.S. Savkur;T.P. Burris

  326
  Citations

• The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing.

  Aria Baniahmad;Xiaohua Leng;T. P. Burris;S. Y. Tsai

  325
  Citations

• Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor

  Keith R. Stayrook;Kelli S. Bramlett;Rajesh S. Savkur;James Ficorilli

  325
  Citations

• Nuclear Receptors and Their Selective Pharmacologic Modulators

  Thomas P. Burris;Laura A. Solt;Yongjun Wang;Christine Crumbley

  296
  Citations

• Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions

  Anne-Marie Leduc;John O. Trent;James L. Wittliff;Kelli S. Bramlett

  280
  Citations

• Action of RORs and their ligands in (patho)physiology

  Laura A. Solt;Thomas P. Burris

  274
  Citations

• PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes.

  Patricia D. Pelton;Lubing Zhou;Keith T. Demarest;Thomas P. Burris

  260
  Citations

• Expression of DAX-1, the Gene Responsible for X-Linked Adrenal Hypoplasia Congenita and Hypogonadotropic Hypogonadism, in the Hypothalamic-Pituitary-Adrenal/Gonadal Axis

  W.W. Guo;T.P. Burris;E.R.B. Mccabe

  246
  Citations

• International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands

  Arthur Christopoulos;Jean Pierre Changeux;William A. Catterall;Doriano Fabbro

  233
  Citations

• T0901317 is a dual LXR/FXR agonist.

  Keith A. Houck;Kristen M. Borchert;Christopher D. Hepler;Jeffrey S. Thomas

  230
  Citations